GlassScriptPhysician profile
Ryan S Labovitch
NPI 1003914318
$3,986.29
in general payments reported to CMS, 2019-2025
27 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $362 · 2021: $149 · 2022: $1,343 · 2023: $142 · 2024: $1,539 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,539 · Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,539.00 |
| Food and Beverage | $336.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $1,539.00 | 2024 | |
| Saxum Surgical, INC. | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $248.35 | 2019-2025 | Orthovisc, Monovisc |
| Arthrex, INC. | $170.45 | 2025 | |
| Abbott Laboratories | $124.24 | 2019-2021 | |
| Bioventus LLC | $76.51 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $75.00 | 2022-2023 | Senza |
| Boston Scientific Corporation | $67.91 | 2020 | |
| Stryker Corporation | $56.54 | 2020 | |
| Globus Medical, INC. | $46.33 | 2021 | |
| Zimmer Biomet Holdings, INC. | $44.60 | 2020 | |
| Fidia Pharma USA INC. | $37.35 | 2019-2023 | Triluron, Hymovis |
| Forte Bio-Pharma LLC | $35.81 | 2019-2020 | |
| Smith+Nephew, INC. | $29.60 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame, Na |
| Breg, INC | $24.79 | 2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $24.52 | 2022 | |
| Linvatec Corporation | $24.48 | 2019 | |
| Zyla Life Sciences, INC. | $24.16 | 2019 | |
| Orthogenrx INC. | $18.73 | 2019 | |
| Nalu Medical, INC. | $17.67 | 2022 | |
| Relievant Medsystems, INC. | $16.79 | 2023 | Intracept |
| Pfizer INC. | $16.31 | 2020 | |
| Si-Bone, INC. | $14.53 | 2021 | |
| Vericel Corporation | $14.51 | 2021 | |
| Medtronic USA, INC. | $13.53 | 2020 | |
| Horizon Therapeutics Plc | $12.79 | 2020 | |
| Convatec INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Labovitch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.